Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
All >

Deals > Northern Europe

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Northern Europe or involving organisations from these countries.

Total search results: 2985 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Orchard Therapeutics–JPMorgan Chase: investor conference, 201901 supply service Orchard presents at JP Morgan Healthcare Conference 2019 2019-01-09
Exscientia–Celgene: investment, 201901 financing round Series B totalling $26m incl new investor Celgene Corp 2019-01-07
Exscientia–Evotec: investment, 201901 financing round Series B totalling $26m incl $6m from existing investor Evotec AG 2019-01-07
Exscientia–GT Healthcare Capital Partners: investment, 201901 financing round Series B totalling $26m incl new investor GT Healthcare Capital Partners 2019-01-07
Exscientia–SEVERAL: investment, 201901 financing round Series B $26m incl Celgene Corp + GT Heallthcare Capital Partners + Evotec 2019-01-07
F2G Ltd–Optimum Strategic Communications: public relations, 201901 service existent by Optimum 2019-01-07
Sophia Genetics–Balderton Capital: investment, 201901 financing round totalling $77m incl existing + co-investor Balderton Capital 2019-01-04
Sophia Genetics–Generation Investment Management: investment, 201901 financing round totalling $77m incl new + lead investor Generation 2019-01-04
Fujifilm–Zyme Communications: public relations, 201901 service existent for Fujifilm Irvine Scientific by Zyme 2019-01-02
Vedanta Biosciences–Invesco: investment, 201812 financing round Series C totalling $27m incl existing investor Invesco Asset Management 2018-12-24
Vedanta Biosciences–PureTech Health: investment, 201812 financing round Series C totalling $27m incl existing investor PureTech Health 2018-12-24
Nabriva–Hercules Technology: credit, 201812–202306 term loan up to $75m with $25m up front von Hercules Capital 2018-12-21
Morphogen-IX–Cambridge Innovation Capital: investment, 201812 financing round Series B totalling £18.4m incl existing + co-investor CIC 2018-12-20
Morphogen-IX–Medicxi Ventures: investment, 201812 financing round Series B totalling £18.4m incl existing + lead investor Medicxi 2018-12-20
Morphogen-IX–SEVERAL: investment, 201812 financing round Series B £18.4m ($23.2m) led by Medicxi + incl CIC + Cambridge Enterprise 2018-12-20
Morphogen-IX–Univ Cambridge: investment, 201812 financing round Series B totalling £18.4m incl existing + co-investor Cambridge Enterprise 2018-12-20
Orchard Therapeutics–Sirion Biotech: gene therapy manufacturing technology, 201812– license for stem cell gene therapies 2018-12-14
Synthace–SEVERAL: investment, 201812 financing round Series B $25.6m led by Horizons Ventures 2018-12-12
AstraZeneca–Cancer Research UK: functional genomics, 201812– collab establishment of joint venture Functional Genomics Centre in Cambridge 2018-12-10
Genomics plc–F-Prime: investment, 201812 financing round Series B 2nd closing totalling £8m from Foresite Capital + F-Prime Capital 2018-12-10
Genomics plc–Foresite Capital: investment, 201812 financing round Series B 2nd closing totalling £8m from Foresite Capital + F-Prime Capital 2018-12-10
Genomics plc–SEVERAL: investment, 201812 financing round Series B 2nd closing £8m from Foresite Capital + F-Prime Capital bringing total round to £33m 2018-12-10
Lonza–General Electric: biologics manufacuturing technology, 201812–2020 supply biologics facility in Guangzhou using KUBio platform by GE Healthcare 2018-12-10
Spatial Transcriptomics–10x Genomics: investment, 201812 acquisition of Spatial by 10x Genomics 2018-12-10
Hookipa–Valneva: drug development services, 201812–202111 collab + manufacturing agreem for developm of immunotherapies with Valneva Sweden AB 2018-12-06
Leo Pharma–Evotec: drug discovery services, 201812– collab €na integrated drug discovery to generate leads against innovative dermatic targets 2018-12-04
Tesaro–GSK: investment, 201812– acquisition $5.1b (£4b) in cash incl net debt assumption of Tesaro Inc by GSK ANNOUNCED 2018-12-03
Aprea–SEVERAL: investment, 201812 financing round Series C €50m led by new investor Redmile Group 2018-12-02
Igem Therapeutics–SEVERAL: investment, 201811 financing round Series £3m final closing bringing total round to £5m 2018-11-30
Argen-X–Piper Jaffray: investor conference, 201811 supply service Argenx presents at Piper Jaffray Healthcare Conference in NYC 2018-11-28
F2G Ltd–Evercore: investor conference, 201811 supply service F2G presents at Evercore ISI HealthCONx Conference 2018 2018-11-28
ABP (NL)–Optimum Strategic Communications: public relations, 201811 service existent by Optimum for Inkef Capital 2018-11-27
Genomics Medicine Ireland–Wuxi PharmaTech: investment, 201811 acquisition of Ireland Medicine Ireland by WuXi NextCode 2018-11-27
Nabriva–Piper Jaffray: investor conference, 201811 supply service Nabriva presents at Piper Jaffray Healthcare Conference in NYC 2018-11-27
Fluidic Analytics–Amadeus Capital: investment, 201811 financing round totalling $31m incl existing + co-investor Amadeus Capital Partners 2018-11-26
Fluidic Analytics–Draper Esprit: investment, 201811 financing round totalling $31m incl existing + lead investor Draper Esprit 2018-11-26
Fluidic Analytics–IQ Capital: investment, 201811 financing round totalling $31m incl existing + co-investor IQ Capital 2018-11-26
Immune Regulation–Instinctif Partners: public relations, 201811 service existent by Instinctif 2018-11-26
Suntory–BRAIN: food ingredients, 201811– collab €na developm natural beverage solutions with SBFE 2018-11-26
Oxford BioMedica–United Kingdom (govt): grant, 201811 Innovate UK grant £2m to support digitallisation of gene/cell therapy production 2018-11-23
Kyowa Hakko Kirin–GSK: daprodustat, 201811– collab €na commercialisation of daprodustat in Japan by Kyowa Hakko Kirin 2018-11-22
OMass–SEVERAL: investment, 201811 financing round Series A £14m led by new investor Syncona Ltd plus Oxford Sciences Innovation 2018-11-21
OMass–Univ Oxford: investment, 201811 financing round Series A totalling £14m incl existing + co-investor Oxford Sciences Innovation 2018-11-21
OMass–Wellcome Trust: investment, 201811 financing round Series A totalling £14m incl new + lead investor Syncona Ltd 2018-11-21
BridgeBio–Leo Pharma: investment, 201811 acquisition minority stake in PellePharm Inc plus r+d funding + plus option to aquire PellePharm 2018-11-20
Inflazome–Forbion: investment, 201811 financing round Series B totalling €40m incl new + lead investor Forbion Capital Partners 2018-11-19
Inflazome–Fountain Healthcare Partners: investment, 201811 financing round Series B totalling €40m incl existing + co-investor FHP 2018-11-19
Inflazome–Longitude Capital: investment, 201811 financing round Series B totalling €40m incl new + co-investor Longitude Capital 2018-11-19
Inflazome–Novartis: investment, 201811 financing round Series B totalling €40m incl existing + co-investor Novartis Venture Fund 2018-11-19
Inflazome–SEVERAL: investment, 201811 financing round Series B €40m from Forbion + Longitude Capital + NVF + Fountain Healthcare Partners 2018-11-19
Roche–Immunocore: ImmTAC technology, 201811– collab expansion co-developm of IMC-C103C with $100m upfront/near-term with Genentech 2018-11-19
Aimmune Therapeutics–Leucadia: investor conference, 201811 supply service Aimmune attends Jefferies 2018 London Healthcare Conference 2018-11-15
Argen-X–Leucadia: investor conference, 201811 supply service Argenx presents at Jefferies 2018 London Healthcare Conference 2018-11-15
Helomics–United Kindgom (govt): personalised medicine, 201811– collab access to 100k Genomces Project data for precision medicine for ovarian cancer 2018-11-15
Allogene Therapeutics–Leucadia: investor conference, 201811 supply service Allogene presents at Jefferies 2018 London Healthcare Conference 2018-11-14
Erytech–Leucadia: investor conference, 201811 supply service Erytech at Jefferies London Healthcare Conference 2018 2018-11-14
Oryzon Genomics–Leucadia: investor conference, 201811 supply service Oryzon attends Jefferies London Healthcare Conference 2018 2018-11-14
Thermo Fisher–Leucadia: investor conference, 201811 supply service Thermo presents at Jefferies London Healthcare Conference 2018 2018-11-14
Hox Therapeutics–Optimum Strategic Communications: public relations, 201811 service existent by Optimum 2018-11-13
Edinburgh Molecular Imaging–Optimum Strategic Communications: public relations, 201811 service existent by Optimum 2018-11-08
Orchard Therapeutics–SEVERAL: investment, 201811 IPO $225.5m with 16.1m ADSs at $14/ADS at Nasdaq Global Select Market 2018-11-05
Cristal Therapeutics–Instinctif Partners: public relations, 201811 service existent by Instinctif 2018-11-02
DefiniGen–MIT: CRISPR technology, 201810– commercial license to CRISPR-Cas9 gene editing technology from Broad Institute 2018-10-30
Grünenthal–AstraZeneca: esomeprazole, 201810– acquisition $922m of European rights to Nexium + ww ex US+JP rights to Vimovo 2018-10-30
Symphogen–Thermo Fisher: mass spectrometer, 201810 supply Q Exactive Plus Orbitrap LC-MS/MS with BioPharma Option for biopharma QC 2018-10-29
Thermo Fisher–Symphogen: mass spectrometry, 201810– collab developm biopharma QC workflows using Q Exactive Plus Orbitrap LC-MS/MS system 2018-10-29
Galecto Biotech–OrbiMed: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor OrbiMed 2018-10-26
Galecto Biotech–SEVERAL: investment, 201810 financing round Series C €79m co-led by Ysios Capital + OrbiMed 2018-10-26
Galecto Biotech–Ysios Capital: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor Ysios Capital 2018-10-26
Euformatics–EU (govt): grant, 201810– H2020 grant €700k for participation in GEMMA project 2018-10-25
Milestone Pharmaceuticals–Novo Group: investment, 201810 financing round private totalling $80m incl existing + co-investor Novo Holdings A/S 2018-10-25
Microbiotica–BPCE: investment, 201810 investment £4m by Seventure Partners’ Health for Life Capital Fund 2018-10-24
Microbiotica–Wellcome Trust: investment, 20810 exising investor Wellcome Sanger Institute 2018-10-24
Zelluna–Image Box: public relations, 201810 supply service existent by Image Box PR 2018-10-24
AstraZeneca–United Kingdom (govt): mass spectrometry, 201810– collab with Medicinces Discovery Catapult on acoustic mist ionisation mass spectrometry 2018-10-22
Amgen–Oxford Nanopore: DNA sequencing technology, 201810 supply existent deCODE Genetics uses Oxford Nanopore technology 2018-10-18
Oxford Nanopore–Amgen: investment, 201810 investment £50m ($66m) acquisition of ordinary shares at same price as 3/18 fundraising 2018-10-18
Arcis:Altos–Zyme Communications: public relations, 201810 service existent by Zyme for Arcis Biotechnology 2018-10-16
Centre for Personalised Medicine (EU)–Randox: personalised medicine, 201811– collab Randox is partner in EU cross-border project 2018-10-16
Genedata–AstraZeneca: bioinformatics, 2018 collab existent development of Genedata Imagence s/w for HCS image analysis 2018-10-16
GSK–Warp Drive Bio: drug discovery, 201810 collab existent in oncology 2018-10-16
Immunicum–SEVERAL: investment, 201810– capital increase SEK351m with 40.3m new shares at SEK8.5/share 2018-10-16
JnJ–MeiraGTx: gene therapy, 201810– collab €na research + evaluation of riboswitch technology to regulate gene therapy constructs of JnJ Innovation 2018-10-16
Teleflex–Arcis:Altos: nucleic acid sample preparation technology, 201810– license to Teleflex from Arcis Biotechnology 2018-10-16
MeiraGTx–Chardan: investor conference, 201810 supply service MeiraGTx presents at Chardan Genetic Medicines Conference in New York 2018-10-09
MeiraGTx–W2O Group: public relations, 201810 service existent PR by W2O pure 2018-10-09
Rgenix–Novo Group: investment, 201810 financing round Series C totalling $40m incl existing + co-investor Novo Holdings AS 2018-10-09
Vector Neurosciences–MeiraGTx: investment, 201810 acquisition in all-stock transaction by MeiraGTx 2018-10-05
Axcelead–ERS Genomics: CRISPR technology, 201810– license non-excl ww to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Celyad–Horizon Discovery: shRNA technology, 201810– license excl to develop allogeneic CAR-T cell therapies 2018-10-04
GenAhead Bio–ERS Genomics: CRISPR technology, 201810– license non-excl to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Iqvia–United Kingdom (govt): clinical genomics, 201810– collab to develop integrated platform with clinical + genomics data with Genomics England 2018-10-04
Arcis:Altos–SEVERAL: investment, 201810 financing round £1.25m of Arcis Biotechnology from existing + new investors 2018-10-02
Arcis:Altos–SEVERAL: investment, 201810– crowd funding round targeting £0.5m of Arcis Biotechnology via Capital Cell 2018-10-02
Evonetix–Magic Micro: DNA synthesis technology, 201810– collab developm of MEMS for DNA synthesis with LioniX Intl 2018-10-01
Nabriva–Cantor Fitzgerald: investor conference, 201810 supply service Nabriva presents at Cantor Fitzegerald Global Healthcare Conference in NY 2018-10-01
Owlstone–Foxconn: investment, 201810 financing round totalling additional $35m incl new + co-investor Foxconn Technology Group 2018-10-01
Owlstone–Horizons Ventures: investment, 201810 financing round totalling additional $35m incl existing + lead investor Horizons Ventures 2018-10-01
Owlstone–SEVERAL: investment, 201810 financing round additional $35m (£27m) bringing total to $50m led by Horizons Ventures 2018-10-01
Owlstone–Ventura Capital: investment, 201810 financing round totalling additional $35m incl new + co-investor Ventura Capital 2018-10-01
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top